Delhi Food Safety Dept. Restricts Unauthorised Inspections
Delhi Food Safety Department mandates written approval from Commissioner for all inspections, aiming to curb misuse of power and arbitrary checks. Learn about the new directive.
Category : Search result: pharma inspections
Ajanta Pharma's Semaglutide Deal Boosts Growth Prospects
Ajanta Pharma partners with Biocon to market weight-loss drug semaglutide in 26 markets. Deal expected to add ₹200 crore sales by FY28, enhancing its branded generics focus. Read more.
Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Orange Biotech PCD Pharma Franchise: Lucrative Business Opportunity
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
Maharashtra FDA's 21-Day New Year Food Safety Drive
Maharashtra FDA launches a 21-day intensive inspection campaign targeting hotels and restaurants from Dec 26 to Jan 15 to ensure safe, unadulterated food during New Year celebrations. Minister Narhari Zirwal directs thorough checks.
India Announces Reforms to Simplify Import Checks
India unveils major reforms to simplify import inspections, a key move to boost trade and secure a long-awaited free trade agreement with the United States. Learn the details.
Noida food safety inspections intensify before Christmas
Noida food safety department ramps up checks at bakeries and food units before Christmas. 12 samples collected for lab testing to ensure hygiene and FSSAI compliance. Details inside.
Aurobindo Pharma increases stake in China JV to 50%
Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.
Ajanta Pharma & Biocon Partner for Generic Weight Loss Drug
Ajanta Pharma partners with Biocon to distribute generic semaglutide in 26 Asian and African markets. The move targets the booming GLP-1 market post-patent expiry, leveraging Ajanta's strong distribution network.
JioHotstar Series Questions India's Pharmaceutical System
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
India Pharma Targets $500B, Innovation Hub by 2047
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
Iran's Fusion Bomb Claim Alarms Israel; Nuke Chief Warns
Iran explores a 'fourth-generation' pure fusion nuclear weapon, a tech no nation has mastered. Tensions soar as IAEA access remains limited. Read the full analysis.
UST & IIT Madras Partner to Nurture Deep-Tech Healthcare Startups
UST and IIT Madras Incubation Cell sign MoU to accelerate healthcare startups. 'Pitch to Win: Pharma 4.0' challenge sees 90+ entries. Winners get funding up to Rs 45 lakh. Read more.
Sonipat Trader Held in Rs 118 Cr GST Evasion Case
CGST Rohtak arrests Sonipat pharma trader Pawel Garg for alleged GST evasion of Rs 21.30 crore on sales of Rs 118.49 crore. Raid uncovers unaccounted transactions. Read the full details.
Rajit Kapur's Malayalam comeback after 25 years
National Award-winning actor Rajit Kapur discusses his return to Malayalam cinema with the medical drama 'Pharma', his role as Dr. Rajiv Rao, and the rise of South Indian OTT content.
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Nivin Pauly's 'Pharma' Web Series Review: A Must-Watch Thriller
Nivin Pauly's 'Pharma', Malayalam's first medical drama web series, is now streaming. Our review explores its gripping plot, stellar cast, and why it's a binge-worthy thriller. Watch now!
HHRC Cracks Down on Illegal Mining in Panchkula
Haryana Human Rights Commission mandates unannounced inspections every 30 days, holds pollution board accountable for lapses in Panchkula. Next hearing on Feb 26, 2026.
Sun Pharma Shares Fall 3% Post-US FDA Inspection
Sun Pharmaceutical shares fell over 3% after a US FDA inspection at its Baska plant. The inspection concluded with 3 observations. Get the full details on the market impact and company's response.
Nivin Pauly's Pharma Web Series Premieres Dec 19 on JioHotstar
Malayalam star Nivin Pauly headlines 'Pharma', a hard-hitting web series on the dark side of the pharmaceutical industry. Premieres December 19, 2025, on JioHotstar in 5 languages.
60% Drop in US Truck Safety Checks, Legal Team Deployed
Amid a sharp 60% decline in federal truck safety inspections, Abogado Piri launches a rapid response team for Texas families affected by crashes. Learn about the legal recourse available.
Odisha Pharma Summit 2025 garners Rs 7,043 crore proposals
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Odisha Pharma Policy 2025 Launch: CM Majhi Unveils Strategy
Odisha CM Mohan Charan Majhi launches the Pharmaceutical and Medical Devices Policy 2025, aiming to attract investments and create jobs. The state announces two dedicated industrial parks. Read more.
Corona Remedies IPO Opens: Key Details & Strong GMP
Corona Remedies IPO subscription starts Dec 8. Price band ₹1008-1062, aims to raise ₹655 cr. Grey market premium signals strong investor interest. Details inside.
Corona Remedies IPO Subscription Begins, GMP at ₹290
Corona Remedies' ₹655 crore IPO opens today. With a price band of ₹1,008-₹1,062 and a strong GMP, analysts give a 'Subscribe for long term' rating. Key dates and details inside.
Odisha Approves Pharma & Medtech Policy 2025
Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.
Himachal Pharma Sector Faces Major Trust Crisis
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
Nivin Pauly's 'Pharma' Trailer Targets Unethical Drug Practices
Nivin Pauly's OTT debut 'Pharma' trailer reveals a medical rep exposing dangerous drugs. The series premieres on JioCinema December 19 in 7 languages. Read more.
Laurus Labs aims for 50% revenue from CDMO business in 5 years
Hyderabad's Laurus Labs plans aggressive CDMO growth, targeting 50% of revenue in five years. CEO Dr. Satyanarayana Chava reveals strategy focusing on cell & gene therapy and global expansion. Read more.
Granules India's US facility passes FDA GMP inspection
Granules India's US subsidiary, Granules Consumer Health LLC, successfully cleared a USFDA GMP inspection with zero observations. This marks a significant achievement for the Hyderabad-based pharma major's OTC product operations in America.
Page 1 of 4